Stool guaiac test (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Stool guaiac test" in English language version.

refsWebsite

Global rank English rank

32nih.gov

4^th place

29doi.org

2^nd place

10semanticscholar.org

11^th place

8^th place

2fda.gov

447^th place

338^th place

2web.archive.org

1^st place

2docs.google.com

1,047^th place

1,015^th place

1medind.nic.in

low place

1vaoutcomes.org

low place

1psu.edu

207^th place

136^th place

1harvard.edu

18^th place

17^th place

1freepatentsonline.com

5,449^th place

3,875^th place

1unl.edu

1,708^th place

1,051^st place

1archive.today

14^th place

1practicalgastro.com

low place

1uptodate.com

3,771^st place

2,605^th place

1hhs.gov

5,973^rd place

3,693^rd place

archive.today

"National Guideline Clearinghouse | Colorectal cancer screening clinic…". archive.ph. August 2, 2012.

docs.google.com

"Michigan Regional Laboratory System. Fecal occult blood". August 2007. Retrieved October 26, 2010.
"None" (PDF).

doi.org

Rex DK, Johnson, DA, Anderson, JC, Schoenfeld, PS, Burke, CA, Inadomi, JM, American College of, Gastroenterology (Mar 2009). "American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]". The American Journal of Gastroenterology. 104 (3): 739–50. doi:10.1038/ajg.2009.104. PMID 19240699. S2CID 295873.
Bretthauer M (August 2010). "Evidence for colorectal cancer screening". Best Pract Res Clin Anaesthesiol. 24 (4): 417–25. doi:10.1016/j.bpg.2010.06.005. PMID 20833346.
Mandel JS, Bond JH, Church TR, et al. (1993). "Reducing mortality from colorectal cancer by screening for fecal occult blood". N Engl J Med. 328 (19): 1365–71. doi:10.1056/nejm199305133281901. PMID 8474513.
Hardcastle JD, Chamberlain JO, Robinson MH, et al. (1996). "Randomised controlled trial of fecal occult blood screening for colorectal cancer". Lancet. 348 (9040): 1472–77. doi:10.1016/s0140-6736(96)03386-7. PMID 8942775. S2CID 11395104.
Kronborg O, Fenger C, Olsen J, et al. (1996). "Randomised study of screening for colorectal cancer with fecal occult blood test". Lancet. 348 (9040): 1467–71. doi:10.1016/s0140-6736(96)03430-7. PMID 8942774. S2CID 37515050.
Kewenter J, Brevinge H, Engaras B, et al. (1994). "Results of screening, rescreening and follow up in a prospective randomized study for detection of colorectal cancer by fecal occult-blood testing: results of 68,308 subjects". Scand J Gastroenterol. 29 (5): 468–73. doi:10.3109/00365529409096840. PMID 8036464.
Collins JF, Lieberman DA, Durbin TE, Weiss DG (January 2005). "Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice" (PDF). Annals of Internal Medicine. 142 (2): 81–5. CiteSeerX 10.1.1.580.829. doi:10.7326/0003-4819-142-2-200501180-00006. PMID 15657155. S2CID 29833684.
Kratochvil JF, et al. (1971). "Isolation and characterization of alpha-guaiaconic acid and the nature of guiacum blue". Phytochemistry. 10 (10): 2529–2531. Bibcode:1971PChem..10.2529K. doi:10.1016/s0031-9422(00)89901-x.
Jaffe RM, Kasten B, Young DS, MacLowry JD (December 1975). "False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C)". Annals of Internal Medicine. 83 (6): 824–6. doi:10.7326/0003-4819-83-6-824. PMID 1200528.
Garrick DP, Close JR, McMurray W (October 1977). "Detection of occult blood in faeces". Lancet. 2 (8042): 820–1. doi:10.1016/S0140-6736(77)90753-X. PMID 71626. S2CID 5822559.
Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA (May 1985). "Fecal blood levels in health and disease. A study using HemoQuant". N. Engl. J. Med. 312 (22): 1422–8. doi:10.1056/NEJM198505303122204. PMID 3873009.
Macrae FA, St John DJ (May 1982). "Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas". Gastroenterology. 82 (5 Pt 1): 891–8. doi:10.1016/S0016-5085(82)80252-7. PMID 7060910.
Grossman MI, Matsumoto KK, Lichter RJ (March 1961). "Fecal blood loss produced by oral and intravenous administration of various salicylates". Gastroenterology. 40 (3): 383–8. doi:10.1016/S0016-5085(61)80070-X. PMID 13709097.
Pierson RN, Holt PR, Watson RM, Keating RP (August 1961). "Aspirin and gastrointestinal bleeding. Chromate blood loss studies". Am. J. Med. 31 (2): 259–65. doi:10.1016/0002-9343(61)90114-0. PMID 13735596.
Norfleet RG (April 1983). "1,300 mg of aspirin daily does not cause positive fecal hemoccult tests". J. Clin. Gastroenterol. 5 (2): 123–5. doi:10.1097/00004836-198304000-00006. PMID 6304182.
Doubilet P, Donowitz M, Pauker SG (1982). "Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin: a Bayesian viewpoint". Med Decis Making. 2 (2): 147–60. doi:10.1177/0272989x8200200206. PMID 7167043. S2CID 39268097.
Bahrt KM, Korman LY, Nashel DJ (November 1984). "Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs". Arch. Intern. Med. 144 (11): 2165–6. doi:10.1001/archinte.144.11.2165. PMID 6333854.
Laine LA, Bentley E, Chandrasoma P (February 1988). "Effect of oral iron therapy on the upper gastrointestinal tract. A prospective evaluation". Dig. Dis. Sci. 33 (2): 172–7. doi:10.1007/BF01535729. PMID 3257437. S2CID 10139402.
Imperiale TF (September 2010). "Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?". Am. J. Gastroenterol. 105 (9): 2036–9. doi:10.1038/ajg.2010.269. PMID 20818354. S2CID 22003870.
Jaffin BW, Bliss CM, LaMont JT (August 1987). "Significance of occult gastrointestinal bleeding during anticoagulation therapy". Am. J. Med. 83 (2): 269–72. doi:10.1016/0002-9343(87)90697-8. PMID 3497580.
Barada K, Abdul-Baki H, El Hajj II, Hashash JG, Green PH (January 2009). "Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy". J. Clin. Gastroenterol. 43 (1): 5–12. doi:10.1097/MCG.0b013e31811edd13. PMID 18607297. S2CID 25371088.
Levin B, Lieberman DA, McFarland B, et al. (May 2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". Gastroenterology. 134 (5): 1570–95. doi:10.1053/j.gastro.2008.02.002. PMID 18384785. Also published as Levin B, Lieberman DA, McFarland B, et al. (2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". CA Cancer J Clin. 58 (3): 130–60. doi:10.3322/CA.2007.0018. PMID 18322143. S2CID 8199010.
Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC (August 2010). "Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations". J Gen Intern Med. 25 (8): 833–9. doi:10.1007/s11606-010-1328-7. PMC 2896587. PMID 20383599.
Rockey DC (July 1999). "Occult gastrointestinal bleeding". N. Engl. J. Med. 341 (1): 38–46. doi:10.1056/NEJM199907013410107. PMID 10387941.
Herzog P, Holtermüller KH, Preiss J, et al. (November 1982). "Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test". Gastroenterology. 83 (5): 957–62. doi:10.1016/S0016-5085(82)80061-9. PMID 7117808.
Rockey DC (December 2005). "Occult gastrointestinal bleeding". Gastroenterol. Clin. North Am. 34 (4): 699–718. doi:10.1016/j.gtc.2005.08.010. PMID 16303578.
Zappa M, Visioli CB, Ciatto S, et al. (April 2007). "Gastric cancer after positive screening faecal occult blood testing and negative assessment". Dig Liver Dis. 39 (4): 321–6. doi:10.1016/j.dld.2006.11.010. PMID 17314076.
Bond JH (April 2007). "FOBT is not an effective way to screen for gastric cancer". Dig Liver Dis. 39 (4): 327–8. doi:10.1016/j.dld.2006.12.013. PMID 17317346.
Allard J, Cosby R, Del Giudice ME, Irvine EJ, Morgan D, Tinmouth J (February 2010). "Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline". Can. J. Gastroenterol. 24 (2): 113–20. doi:10.1155/2010/516363. PMC 2852233. PMID 20151070.

fda.gov

"Guidance for Industry and FDA Staff — Review Criteria for Assessment of Qualitative Fecal Occult Blood In Vitro Diagnostic Devices". United States Food and Drug Administration Office of In Vitro Diagnostic Device Evaluation and Safety. August 8, 2007.
"Fecal occult blood". www.fda.gov. Retrieved October 26, 2010.

freepatentsonline.com

Guthlein W, Wielinger H, Rittersdorf W, Werner W. "Guaiaconic acid A from guaiac resin, US Patent 4297271" (PDF). Free Patents Online.

harvard.edu

ui.adsabs.harvard.edu

Kratochvil JF, et al. (1971). "Isolation and characterization of alpha-guaiaconic acid and the nature of guiacum blue". Phytochemistry. 10 (10): 2529–2531. Bibcode:1971PChem..10.2529K. doi:10.1016/s0031-9422(00)89901-x.

hhs.gov

cms.hhs.gov

Centers for Medicare and Medicaid Services. Colorectal cancer: Preventable, treatable and beatable: Medicare coverage and billing for colorectal cancer screening. Medicare Learning Network Matters SE0710. www.cms.hhs.gov/MLNMattersArticles/downloads/SE0710.pdf Accessioned 2010 November 1

medind.nic.in

Beg M, et al. (2002). "Occult Gastrointestinal Bleeding: Detection, Interpretation, and Evaluation" (PDF). JIACM. 3 (2): 153–8. Archived from the original (PDF) on 2010-11-22. Retrieved 2010-10-26.

nih.gov

pubmed.ncbi.nlm.nih.gov

Rex DK, Johnson, DA, Anderson, JC, Schoenfeld, PS, Burke, CA, Inadomi, JM, American College of, Gastroenterology (Mar 2009). "American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]". The American Journal of Gastroenterology. 104 (3): 739–50. doi:10.1038/ajg.2009.104. PMID 19240699. S2CID 295873.
Bretthauer M (August 2010). "Evidence for colorectal cancer screening". Best Pract Res Clin Anaesthesiol. 24 (4): 417–25. doi:10.1016/j.bpg.2010.06.005. PMID 20833346.
Mandel JS, Bond JH, Church TR, et al. (1993). "Reducing mortality from colorectal cancer by screening for fecal occult blood". N Engl J Med. 328 (19): 1365–71. doi:10.1056/nejm199305133281901. PMID 8474513.
Hardcastle JD, Chamberlain JO, Robinson MH, et al. (1996). "Randomised controlled trial of fecal occult blood screening for colorectal cancer". Lancet. 348 (9040): 1472–77. doi:10.1016/s0140-6736(96)03386-7. PMID 8942775. S2CID 11395104.
Kronborg O, Fenger C, Olsen J, et al. (1996). "Randomised study of screening for colorectal cancer with fecal occult blood test". Lancet. 348 (9040): 1467–71. doi:10.1016/s0140-6736(96)03430-7. PMID 8942774. S2CID 37515050.
Kewenter J, Brevinge H, Engaras B, et al. (1994). "Results of screening, rescreening and follow up in a prospective randomized study for detection of colorectal cancer by fecal occult-blood testing: results of 68,308 subjects". Scand J Gastroenterol. 29 (5): 468–73. doi:10.3109/00365529409096840. PMID 8036464.
Collins JF, Lieberman DA, Durbin TE, Weiss DG (January 2005). "Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice" (PDF). Annals of Internal Medicine. 142 (2): 81–5. CiteSeerX 10.1.1.580.829. doi:10.7326/0003-4819-142-2-200501180-00006. PMID 15657155. S2CID 29833684.
Jaffe RM, Kasten B, Young DS, MacLowry JD (December 1975). "False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C)". Annals of Internal Medicine. 83 (6): 824–6. doi:10.7326/0003-4819-83-6-824. PMID 1200528.
Garrick DP, Close JR, McMurray W (October 1977). "Detection of occult blood in faeces". Lancet. 2 (8042): 820–1. doi:10.1016/S0140-6736(77)90753-X. PMID 71626. S2CID 5822559.
Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA (May 1985). "Fecal blood levels in health and disease. A study using HemoQuant". N. Engl. J. Med. 312 (22): 1422–8. doi:10.1056/NEJM198505303122204. PMID 3873009.
Macrae FA, St John DJ (May 1982). "Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas". Gastroenterology. 82 (5 Pt 1): 891–8. doi:10.1016/S0016-5085(82)80252-7. PMID 7060910.
Frame PS, Kowulich BA (December 1982). "Stool occult blood screening for colorectal cancer". J Fam Pract. 15 (6): 1071–5. PMID 7142926.
Grossman MI, Matsumoto KK, Lichter RJ (March 1961). "Fecal blood loss produced by oral and intravenous administration of various salicylates". Gastroenterology. 40 (3): 383–8. doi:10.1016/S0016-5085(61)80070-X. PMID 13709097.
Pierson RN, Holt PR, Watson RM, Keating RP (August 1961). "Aspirin and gastrointestinal bleeding. Chromate blood loss studies". Am. J. Med. 31 (2): 259–65. doi:10.1016/0002-9343(61)90114-0. PMID 13735596.
Norfleet RG (April 1983). "1,300 mg of aspirin daily does not cause positive fecal hemoccult tests". J. Clin. Gastroenterol. 5 (2): 123–5. doi:10.1097/00004836-198304000-00006. PMID 6304182.
Doubilet P, Donowitz M, Pauker SG (1982). "Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin: a Bayesian viewpoint". Med Decis Making. 2 (2): 147–60. doi:10.1177/0272989x8200200206. PMID 7167043. S2CID 39268097.
Bahrt KM, Korman LY, Nashel DJ (November 1984). "Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs". Arch. Intern. Med. 144 (11): 2165–6. doi:10.1001/archinte.144.11.2165. PMID 6333854.
Laine LA, Bentley E, Chandrasoma P (February 1988). "Effect of oral iron therapy on the upper gastrointestinal tract. A prospective evaluation". Dig. Dis. Sci. 33 (2): 172–7. doi:10.1007/BF01535729. PMID 3257437. S2CID 10139402.
Anderson GD, Yuellig TR, Krone RE (May 1990). "An investigation into the effects of oral iron supplementation on in vivo Hemoccult stool testing". Am. J. Gastroenterol. 85 (5): 558–61. PMID 2186616.
Imperiale TF (September 2010). "Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?". Am. J. Gastroenterol. 105 (9): 2036–9. doi:10.1038/ajg.2010.269. PMID 20818354. S2CID 22003870.
Jaffin BW, Bliss CM, LaMont JT (August 1987). "Significance of occult gastrointestinal bleeding during anticoagulation therapy". Am. J. Med. 83 (2): 269–72. doi:10.1016/0002-9343(87)90697-8. PMID 3497580.
Barada K, Abdul-Baki H, El Hajj II, Hashash JG, Green PH (January 2009). "Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy". J. Clin. Gastroenterol. 43 (1): 5–12. doi:10.1097/MCG.0b013e31811edd13. PMID 18607297. S2CID 25371088.
Levin B, Lieberman DA, McFarland B, et al. (May 2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". Gastroenterology. 134 (5): 1570–95. doi:10.1053/j.gastro.2008.02.002. PMID 18384785. Also published as Levin B, Lieberman DA, McFarland B, et al. (2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". CA Cancer J Clin. 58 (3): 130–60. doi:10.3322/CA.2007.0018. PMID 18322143. S2CID 8199010.
Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC (August 2010). "Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations". J Gen Intern Med. 25 (8): 833–9. doi:10.1007/s11606-010-1328-7. PMC 2896587. PMID 20383599.
Rockey DC (July 1999). "Occult gastrointestinal bleeding". N. Engl. J. Med. 341 (1): 38–46. doi:10.1056/NEJM199907013410107. PMID 10387941.
Herzog P, Holtermüller KH, Preiss J, et al. (November 1982). "Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test". Gastroenterology. 83 (5): 957–62. doi:10.1016/S0016-5085(82)80061-9. PMID 7117808.
Rockey DC (December 2005). "Occult gastrointestinal bleeding". Gastroenterol. Clin. North Am. 34 (4): 699–718. doi:10.1016/j.gtc.2005.08.010. PMID 16303578.
Zappa M, Visioli CB, Ciatto S, et al. (April 2007). "Gastric cancer after positive screening faecal occult blood testing and negative assessment". Dig Liver Dis. 39 (4): 321–6. doi:10.1016/j.dld.2006.11.010. PMID 17314076.
Bond JH (April 2007). "FOBT is not an effective way to screen for gastric cancer". Dig Liver Dis. 39 (4): 327–8. doi:10.1016/j.dld.2006.12.013. PMID 17317346.
Allard J, Cosby R, Del Giudice ME, Irvine EJ, Morgan D, Tinmouth J (February 2010). "Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline". Can. J. Gastroenterol. 24 (2): 113–20. doi:10.1155/2010/516363. PMC 2852233. PMID 20151070.

ncbi.nlm.nih.gov

Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC (August 2010). "Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations". J Gen Intern Med. 25 (8): 833–9. doi:10.1007/s11606-010-1328-7. PMC 2896587. PMID 20383599.
Allard J, Cosby R, Del Giudice ME, Irvine EJ, Morgan D, Tinmouth J (February 2010). "Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline". Can. J. Gastroenterol. 24 (2): 113–20. doi:10.1155/2010/516363. PMC 2852233. PMID 20151070.

practicalgastro.com

"Archived copy" (PDF). Archived from the original (PDF) on 2010-11-21. Retrieved 2010-07-18.{{cite web}}: CS1 maint: archived copy as title (link)

psu.edu

citeseerx.ist.psu.edu

Collins JF, Lieberman DA, Durbin TE, Weiss DG (January 2005). "Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice" (PDF). Annals of Internal Medicine. 142 (2): 81–5. CiteSeerX 10.1.1.580.829. doi:10.7326/0003-4819-142-2-200501180-00006. PMID 15657155. S2CID 29833684.

semanticscholar.org

api.semanticscholar.org

Rex DK, Johnson, DA, Anderson, JC, Schoenfeld, PS, Burke, CA, Inadomi, JM, American College of, Gastroenterology (Mar 2009). "American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]". The American Journal of Gastroenterology. 104 (3): 739–50. doi:10.1038/ajg.2009.104. PMID 19240699. S2CID 295873.
Hardcastle JD, Chamberlain JO, Robinson MH, et al. (1996). "Randomised controlled trial of fecal occult blood screening for colorectal cancer". Lancet. 348 (9040): 1472–77. doi:10.1016/s0140-6736(96)03386-7. PMID 8942775. S2CID 11395104.
Kronborg O, Fenger C, Olsen J, et al. (1996). "Randomised study of screening for colorectal cancer with fecal occult blood test". Lancet. 348 (9040): 1467–71. doi:10.1016/s0140-6736(96)03430-7. PMID 8942774. S2CID 37515050.
Collins JF, Lieberman DA, Durbin TE, Weiss DG (January 2005). "Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice" (PDF). Annals of Internal Medicine. 142 (2): 81–5. CiteSeerX 10.1.1.580.829. doi:10.7326/0003-4819-142-2-200501180-00006. PMID 15657155. S2CID 29833684.
Garrick DP, Close JR, McMurray W (October 1977). "Detection of occult blood in faeces". Lancet. 2 (8042): 820–1. doi:10.1016/S0140-6736(77)90753-X. PMID 71626. S2CID 5822559.
Doubilet P, Donowitz M, Pauker SG (1982). "Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin: a Bayesian viewpoint". Med Decis Making. 2 (2): 147–60. doi:10.1177/0272989x8200200206. PMID 7167043. S2CID 39268097.
Laine LA, Bentley E, Chandrasoma P (February 1988). "Effect of oral iron therapy on the upper gastrointestinal tract. A prospective evaluation". Dig. Dis. Sci. 33 (2): 172–7. doi:10.1007/BF01535729. PMID 3257437. S2CID 10139402.
Imperiale TF (September 2010). "Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?". Am. J. Gastroenterol. 105 (9): 2036–9. doi:10.1038/ajg.2010.269. PMID 20818354. S2CID 22003870.
Barada K, Abdul-Baki H, El Hajj II, Hashash JG, Green PH (January 2009). "Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy". J. Clin. Gastroenterol. 43 (1): 5–12. doi:10.1097/MCG.0b013e31811edd13. PMID 18607297. S2CID 25371088.
Levin B, Lieberman DA, McFarland B, et al. (May 2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". Gastroenterology. 134 (5): 1570–95. doi:10.1053/j.gastro.2008.02.002. PMID 18384785. Also published as Levin B, Lieberman DA, McFarland B, et al. (2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". CA Cancer J Clin. 58 (3): 130–60. doi:10.3322/CA.2007.0018. PMID 18322143. S2CID 8199010.

unl.edu

digitalcommons.unl.edu

Levin B, Lieberman DA, McFarland B, et al. (May 2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". Gastroenterology. 134 (5): 1570–95. doi:10.1053/j.gastro.2008.02.002. PMID 18384785. Also published as Levin B, Lieberman DA, McFarland B, et al. (2008). "Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology". CA Cancer J Clin. 58 (3): 130–60. doi:10.3322/CA.2007.0018. PMID 18322143. S2CID 8199010.

uptodate.com

"Screening average risk patients for colorectal cancer — B01". Retrieved 2007-10-25.

vaoutcomes.org

Collins JF, Lieberman DA, Durbin TE, Weiss DG (January 2005). "Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice" (PDF). Annals of Internal Medicine. 142 (2): 81–5. CiteSeerX 10.1.1.580.829. doi:10.7326/0003-4819-142-2-200501180-00006. PMID 15657155. S2CID 29833684.

web.archive.org

Beg M, et al. (2002). "Occult Gastrointestinal Bleeding: Detection, Interpretation, and Evaluation" (PDF). JIACM. 3 (2): 153–8. Archived from the original (PDF) on 2010-11-22. Retrieved 2010-10-26.
"Archived copy" (PDF). Archived from the original (PDF) on 2010-11-21. Retrieved 2010-07-18.{{cite web}}: CS1 maint: archived copy as title (link)